Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ejtwCfbwocfaAlpJkIrk

February 7, 2013
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
 
  • Partnership aims to discover neurological disease markers
    Emerald Logic has partnered with King's College London to uncover biomarkers for neurological diseases including Alzheimer's. Researchers at King's College are using Emerald Logic's Fast Collective Evolution Technology, or FACET, in their work. They have already identified some markers, which, combined with APOE genetic data and demographic information, allowed for development of a method with 94% accuracy in differentiating Alzheimer's disease, mild cognitive impairment and controls, according to Emerald Logic. GenomeWeb Daily News (free registration) (2/5) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
How can we help with your radiation reduction initiatives
The MEDRAD™ Intego™ has helped PET sites across the world reduce unnecessary radiation exposure. Utilizing a fully shielded, mobile design, the system infuses doses-on-demand from a multi-dose vial, providing added protection and more accurate, repeatable, patient-specific dosing. See more here.
  Clinical News & Research 
  ADVERTISEMENT  
Selling your business? Here are 7 things you should do now.
If you're considering selling your business, you should be doing everything you can to get the best possible price. In just 7 simple steps you can improve your chances of attracting buyers and getting big bucks for your business. Read the article and learn the 7 steps.

  Industry Report 
  • AMIC seeks FDA meeting to advance RadioGel
    Advanced Medical Isotope Corp. said it has submitted RadioGel data to the FDA and is seeking a meeting with the agency in a move toward premarket review. RadioGel allows for targeted delivery of high doses of radiation to inoperable tumors while sparing healthy tissue. The company plans to manufacture the product in Washington state and also aims to establish a facility that will include a cyclotron for the production of technetium-99m. Yahoo/Globe Newswire/News release (2/5) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  • B&W Tek unveils new Raman spectrometer
    B&W Tek has launched its portable i-Raman Plus Raman spectrometer, which can assess weak Raman signals. The device is capable of improving signal-to-noise ratio for as long as a half-hour of integration time. The technology features B&W Tek's BWIQ multivariate analysis platform. BioOptics World /News release (1/31) LinkedInFacebookTwitterEmail this Story
  Health Policy 
  • FDA seeks ways to reward quality
    The FDA is considering developing a quality scorecard for drug manufacturers in an effort to prevent quality problems that have contributed to recent drug shortages, according to an article in Clinical Pharmacology & Therapeutics by FDA officials Janet Woodcock and Marta Wosinka. Pharmalot.com/Pharma blog (2/6) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  From SNMMI 
  • Don't miss this half-day Roadshow coming to Hot Springs, Ark., on Feb. 23
    Kick off 2013 with an informative half-day event on embracing change in the field of nuclear medicine and molecular imaging. Join the SNMMI-TS in Hot Springs, Ark., and discuss the regulatory changes impacting nuclear medicine departments and the impact emerging technology has on molecular imaging. Plus, you'll examine recent procedural changes within nuclear medicine departments and identify career paths for Nuclear Medicine Technologists. VOICE credit available. Register today. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  SmartQuote 
I am never bored anywhere: being bored is an insult to oneself."
--Jules Renard,
French author


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.®  Legal Information